Cat Hypertrophic Cardiomyopathy: Monitoring and Management

Hypertrophic cardiomyopathy is the most common heart disease in cats. Early detection and monitoring allows appropriate management that can significantly extend quality and length of life.

Key Facts

HCM affects an estimated 15% of the general cat population and up to 30% of Maine Coons
The condition causes thickening of the left ventricular wall, reducing cardiac output
Many cats are asymptomatic for years before developing signs of heart failure
Cardiac ultrasound (echocardiogram) is the gold standard for diagnosis and monitoring
Arterial thromboembolism (ATE) — blood clots — is a devastating and painful HCM complication
Genetic tests exist for Maine Coon and Ragdoll HCM mutations, aiding breeding decisions

Welfare Considerations

HCM poses profound welfare challenges because it can progress silently until sudden deterioration or ATE causes acute suffering. ATE typically causes sudden paralysis of the hindlimbs and severe pain, often with a poor prognosis. Regular echocardiographic monitoring of at-risk cats enables earlier intervention with medications that may slow progression. Breeders who screen cats and remove affected individuals from breeding programmes reduce the prevalence of inherited HCM in subsequent generations. End-of-life decisions must carefully balance quality of life against quantity, particularly as decompensated heart failure causes significant distress from fluid accumulation.

What You Can Do

Ask your vet about cardiac auscultation as part of annual health checks
Have purebred cats from high-risk breeds screened echocardiographically
If breeding Maine Coons or Ragdolls, use only genetically tested negative cats
Learn the signs of congestive heart failure: laboured breathing, lethargy, open-mouth breathing
Discuss monitoring frequency and treatment options with a veterinary cardiologist
Make end-of-life decisions based on quality of life, consulting pain and distress indicators